Xeomin Clinical Trials
4 recruitingDrug
Phase 34
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Merz Therapeutics GmbH990 enrolled106 locationsNCT07018700
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Chronic Migraine
Merz Therapeutics GmbH780 enrolled106 locationsNCT07018713
Recruiting
Phase 3
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia
Alain Kaelin48 enrolled5 locationsNCT03977493
Recruiting
Phase 3
Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea
Primary Dysmenorrhea
Nantes University Hospital222 enrolled8 locationsNCT06995287